SZM-1209

Overview

SZM-1209 is an orally active, potent and specific RIPK1 inhibitor, with a K d of 85 nM. SZM-1209 exhibits high anti-necroptotic activity ( EC 50 =22.4 ± 8.1 nM). SZM-1209 shows anti-SIRS (systemic inflammatory response syndrome), and anti-ALI (acute lung injury) effects.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > RIP kinase | Products > Signaling Pathways > Mixed Lineage Kinase | Products > Signaling Pathways > Necroptosis

Product Information

• Catalog No.: HY-149052
• CAS No.: 2919801-86-6
• Molecular Formula: C31H29F5N4O5S2
• Molecular Weight: 696.71
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source